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Introduction
RNA processing, localization, and stability from the nucleus to 
the cytoplasm is coordinated by a multitude of RNA-binding 
proteins (RBPs) and microRNAs (Keene, 2007). Although the 
vertebrate genome encodes for hundreds of RBPs, only a small 
fraction of RBP targets and regulatory roles are known to date 
(Halbeisen et al., 2008; Hogan et al., 2008).
Neural crest cells are a transient embryonic stem cell pop-
ulation that contributes to important derivatives in vertebrate 
embryos, including the craniofacial skeleton and peripheral 
nervous system. Although many critical events in neural crest 
development are transcriptionally regulated (Sauka-Spengler 
and Bronner-Fraser, 2008), it is becoming increasingly clear 
that posttranscriptional modifications, such as SUMOylation 
(Taylor and LaBonne, 2005) and RNA stabilization/localiza-
tion, also play important roles (Hogan et al., 2008). However, 
few studies have examined the role of RNA stabilization in 
developmental processes.
Interestingly, defects in RNA processing can lead to 
neural crest-related craniofacial abnormalities. For instance, 
in Treacher Collins Syndrome, disruption of Tcof1, which is 
involved in ribosome biosynthesis, leads to craniofacial abnor-
malities in mice (Dixon et al., 2006). Given that cranial neural 
crest (CNC) anomalies are among the most common of human 
birth defects (McKeown and Bronner-Fraser, 2008), it is clearly 
important to understand the developmental role of RNA stabi-
lization therein.
To this end, we describe the expression and developmen-
tal function of an RBP Rbms3 in craniofacial morphogenesis. 
Isolated in a gene and protein trap screen in zebrafish (Trinh 
et al., 2011), the Rbms3 RBP belongs to the small family of c-myc 
single-stranded binding proteins (MSSPs; Penkov et al., 2000). 
MSSPs contain two ribonucleoprotein (RRM) domains that 
were originally described in RBPs (Siomi et al., 1993) and re-
quired for c-myc promoter binding (Takai et al., 1994). Previ-
ously, Rbms3 was shown to exhibit tumor suppressor function 
via regulation of c-Myc (Li et al., 2011) and to bind/stabilize 
RNA in vitro (Penkov et al., 2000; Fritz and Stefanovic, 2007; 
Lu et al., 2012). However, the in vivo function for Rbms3 dur-
ing development has remained unexplored.
Cranial neural crest cells form much of the facial skeleton, and abnormalities in their development lead to severe birth defects. In a novel zebrafish 
protein trap screen, we identified an RNA-binding pro-
tein, Rbms3, that is transiently expressed in the cytoplasm 
of condensing neural crest cells within the pharyngeal 
arches. Morphants for rbms3 displayed reduced prolifer-
ation of prechondrogenic crest and significantly altered 
expression for chondrogenic/osteogenic lineage markers. 
This phenotype strongly resembles cartilage/crest defects 
observed in Tgf-r2:Wnt1-Cre mutants, which suggests a 
possible link with TGF- signaling. Consistent with this are 
the findings that: (a) Rbms3 stabilized a reporter tran-
script with smad2 3 untranslated region, (b) RNA immuno-
precipitation with full-length Rbms3 showed enrichment for 
smad2/3, and (c) pSmad2 levels were reduced in rbms3 
morphants. Overall, these results suggest that Rbms3 post-
transcriptionally regulates one of the major pathways that 
promotes chondrogenesis, the transforming growth factor 
 receptor (TGF-r) pathway.
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(Fig. 1 A). The full-length rbms3 (exons 2–14) is a 415–
amino acid protein; exons 3–7 code for two putative RNA 
binding domains (RRM).
The Citrine in Gt(rbms3-citrine)ct30a is flanked by splice 
acceptor and donor sites and is incorporated as an artificial 
exon into the Rbms3 protein (Trinh et al., 2011). Homozygous 
Gt(rbms3-citrine)ct30a fish are viable, suggesting that Citrine 
incorporation does not interfere with protein function. Citrine 
(labeling all three rbms3 variants) was observed in the cranial 
mesenchyme, pharyngeal arches neurons within the neural 
tube, the isthmus of the midbrain-hindbrain, fin buds, and tail 
bud/somites (Fig. 1 C). By 48–60 h postfertilization (hpf), Ci-
trine was absent in the tail. At the 10 somite stage (ss; 14 hpf), 
citrine is expressed in the hatching gland, the mesoderm of 
the tail bud and somites. Expression for rbms3 was similar to 
citrine, which confirmed that tagged and endogenous Rbms3 
expression patterns overlapped at 24–60 hpf. By 48 hpf, ex-
pression in the heart was also apparent (Fig. 1 D). Quantitative 
PCR (QPCR) analysis showed that onset of rbms3 expression 
was around 6–10 hpf (gastrulation to 3 ss; Fig. 1 E). By 16–18 
hpf, rbms3 was also expressed in the nervous system and 
cranial mesenchyme (Fig. S1).
CNC emigrate from the neural tube (5–10 ss/11.5–14 
hpf in zebrafish) in a segmental fashion, invade the pharyngeal 
arches, and form prechondrogenic mesenchyme (Schilling 
and Kimmel, 1994; Trainor and Krumlauf, 2001; Knecht and 
Here, we report that Rbms3 is expressed transiently 
in condensing CNC in the pharyngeal arches (Penkov et al., 
2000). Because our protein trap screen labels endogenous 
Rbms3, we find that it is predominantly expressed in the cy-
toplasm of CNC, which suggests that its primary function is 
in RNA metabolism rather than transcriptional regulation of 
c-Myc. Embryonic knockdown of rbms3 results in severe cra-
niofacial defects and a reduction in activated Smad2, a down-
stream effector of TGF- receptor (TGF-r) signaling. We 
present evidence that Rbms3 binds to and stabilizes Smad2 
transcripts. Significantly, our results suggest that zebrafish 
Rbms3 is a novel posttranscriptional regulator of one of the 
major cartilage differentiation effectors, the TGF-r pathway. 
Other novel targets for Rbms3 also include cell cycle regu-
lators (rac1 and cyclin D1) and smad1, which suggests that 
Rbm3 is a global chondrogenic regulator important for driving 
CNC down a chondrogenic lineage.
Results
Zebrafish rbms3 is expressed during 
cartilage formation
In the Rbms3 trapped line, Gt(rbms3-citrine)ct30a (Trinh 
et al., 2011), the insertion of the Citrine tag was localized to 
intron 11. 5 rapid amplification of cDNA ends (RACE) was 
performed to retrieve full-length and two C-terminal variants 
Figure 1. Structure and expression of zebrafish rbms3. (A) Full-
length and rbms3 variants v2 and v3 were identified using RACE. 
(B) Full-length zebrafish Rbms3 is 415 amino acids long. (C and D) 
Endogenous Rbms3 expression as denoted by Citrine expression 
in the Gt(rbms3-citrine)ct30a line (C); this closely resembles rbms3 
transcript expression in wild-type (WT) zebrafish (D). (C) Citrine 
fluorescence is detected in craniofacial structures from 24 hpf to 
60 hpf. 31 hpf and 60 hpf: live whole-mount images. 24 hpf: 
confocal z-stacks of the head region (top) and tail region (bot-
tom) in live Gt(rbms3-citrine)ct30a homozygotes stained with the 
vital dye Bodipy-TR (red). Asterisks indicate Rbms3-expressing 
neurons. cns, central nervous system; cranial ganglia, v, vii, viii, 
ix, and x; f, fin bud; hb, hindbrain; i, isthmus; m, mesenchyme; 
mb, midbrain; o, otic vesicle; pa, pharyngeal arches; s, somites; 
sp, spinal chord; tb, tail bud mesoderm. 31 hpf: confocal sec-
tion of head region showing expression in the pharyngeal arches 
(1–3). (D) Citrine transcript is detected at 10 ss (boxed region in 
the right panel) in the hatching gland (h), tail bud mesoderm (tb), 
and somites (s, outlined). Lateral (top) and dorsal (bottom) views 
shown. (E) QPCR analysis of Rbms3 expression during early 
embryonic development (n = 3). Error bars indicate SD. Bars: 
(C, top two fluorescent images; and D) 200 µM; (C, bottom three 
images) 50 µM.
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Rbms3 does not affect early CNC
Tissue interactions and signaling during gastrulation are essen-
tial for proper CNC formation in the embryo (Rogers et al., 
2012). The cartilage abnormalities observed in rbms3 mor-
phants may be caused by early patterning defects, which subse-
quently affect early CNC formation and migration (Fig. 4).
Analysis of the neural plate boarder markers snail1b and 
foxd3 at 3 ss (10 hpf) showed no differences between controls 
and rbms3 morphants (Fig. 4 A). No significant changes were 
also observed in expression of CNC markers sox10 and foxd3 
at 10 ss (Fig. 4 A).
Rbms3 is expressed in the isthmus at the midbrain–hindbrain 
junction. To rule out the possibility that the cartilage defects in 
rbms3 morphants may be secondary to midbrain–hindbrain pat-
terning defects, we analyzed markers of forebrain (pax6a), isth-
mus (fgf3/pax2a), and hindbrain (hoxa2) at 20 ss (19 hpf). No 
significant differences between controls and rbms3 morphants 
were observed (Fig. 4 C). Collectively, the results suggest that 
early patterning in rbms3 morphants is normal, and that the car-
tilage phenotype is not a secondary defect.
Abnormal PCC development in  
rbms3 morphants
The cartilage phenotype may result from defects in PCC con-
densation and/or differentiation because early CNC develop-
ment was normal in rbms3 morphants. Analysis of dlx2a revealed 
no significant differences in PCC condensation at 24 hpf in 
the pharyngeal arches (Fig. 5 A). At this stage, Rbms3 is only 
weakly expressed and later up-regulated in the pharyngeal 
arches by 31 hpf (Fig. 1 C).
In contrast, significant effects on PCC and its deriva-
tives were observed in rbms3 morphants from 31 hpf to 72 hpf. 
Barx1, sox9a (PCC/chondrocytes), and col2a1a (mature chon-
drocytes) domains of expression were reduced/missing in mor-
phants (Fig. 5 A). QPCR analysis at 48 hpf showed a reduction 
in sox9a and barx1 levels in rbms3 morphants (P < 0.005), yet 
no significant difference in prrx1a (cranial mesenchyme) was 
Bronner-Fraser, 2002). In Gt(rbms3-citrine)ct30a; Tg(sox10(7.2):
mrfp) fish at 31 hpf, Rbms3 (green) colocalizes with CNC cells 
(red) in the pharyngeal arches (Fig. 2, top and middle) in the cy-
toplasm (Fig. 2, middle), which is consistent with a role during 
RNA metabolism (Penkov et al., 2000; Fritz and Stefanovic, 
2007; Lu et al., 2012). By 72 hpf, differentiated cartilage lack 
Rbms3, but surrounding tissue maintain expression (Fig. 2, 
bottom, arrowheads). The expression pattern of Rbms3 in pre-
chondrogenic crest (PCC) suggests it may function transiently 
during cartilage differentiation.
Perturbing rbms3 disrupts craniofacial 
development
We designed two morpholino oligonucleotides (MOs), a trans-
lation blocking translation start site rbms3 morpholino (Atg 
MO) and a splice site rbms3 morpholino (Sp MO), to perform 
rbms3 loss-of-function analysis during zebrafish development. 
Both MOs efficiently blocked Rbms3 production when injected 
into the Gt(rbms3-citrine)ct30a line, as analyzed by Western blot-
ting using an anti-GFP antibody (Fig. 3 A). The Sp MO was 
found to skip exon 3 (Fig. 3 B), creating a truncated transcript; 
sequencing of other minor PCR products also produced other 
truncated transcripts of rbms3 (Fig. 2 A). Survival of morphant 
larvae was reduced past 4 d postfertilization (dpf).
Compared with controls, rbms3 morphants displayed 
cardiac edema, with varying penetrance, smaller body size, a 
hooked head, and craniofacial defects by 3 dpf (Fig. 3 B).
Rbms3 morphants displayed major disruption to neurocra-
nial and pharyngeal cartilage elements (Fig. 3 C; see Fig. 6 A). 
About 80–90% of morphants displayed malformed mandibular 
and hyoid cartilage elements, and with varying penetrance, the 
cartilage of pharyngeal arches 3–7 was either entirely miss-
ing or malformed (Fig. 3, C and D). Co-injecting full-length 
rbms3 with Atg MO was able to fully or partially rescue 
the severe phenotype (Fig. 3 E; 74% severe phenotype with 
Atg MO, n = 97, vs. 20% severe phenotype with Atg MO 
coinjected with rbms3, n = 193, P < 0.001).
Figure 2. Rbms3 is expressed by PCC. Citrine-tagged Rbms3 
is transiently expressed by PCC (arrowheads, yellow/orange) 
in the pharyngeal arches (1–7) at 31 hpf (top two rows) and 
predominantly localized to the cytoplasm (middle row). The 
boxed region in the top left panel is magnified in the middle 
row. At 72 hpf, Rbms3 is excluded by cartilage (asterisks) 
but maintained by surrounding tissue (arrowheads) in the 
pharyngeal arches (1–7; bottom row). Sox10:rfp (red) marks 
PCC and cartilage. Bars: (top) 100 µM; (middle) 10 µM; 
(bottom) 200 µM.
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Figure 3. Craniofacial defects in rbms3 mor-
phants. (A) rbms3 MO design (E2, exon 2; I2, 
intron 2). Atg MO treatment results in knock-
down of Citrine-Rbms3 (middle). Sp MO results 
in skipping of exon 3 (red arrow), and some 
transcripts maintain a portion of intron 3 (i3, 
yellow, black arrow), resulting in truncated 
Rbms3 products. The Sp MO also generates 
other minor splice variants (black arrowheads). 
(B) Atg morphants (boxed larvae) show cranio-
facial defects. (C) Alcian blue cartilage staining 
in Atg MO–treated fish. Top row, lateral view; 
bottom row, ventral view. (D) Quantification 
of cartilage phenotype for Sp and Atg MOs. 
(E) Full-length rbms3 partially/fully rescues Atg 
MO severe phenotype (**, P < 0.001, 2 test). 
n = total number of treated fish from 3–4 ex-
periments (D and E). Error bars indicate SD. 
Bars, 200 µM.
Figure 4. Early CNC and neural development 
in rbms3 morphants. (A) Dorsal view of neu-
ral plate border markers snail1b and foxd3. 
Bracket: anterior-posterior extent of domain is 
unchanged. (B) Pre-migratory foxd3 and sox10 
CNC expression is unchanged. (C) Dorsal views 
of neural marker expression. Fb, forebrain 
(pax6a); hb, hindbrain (pax6a, hox2a); and 
i, isthmic regions (fgf3, pax2a). r2-r5, rhombo-
meres 2–5. Bars, 200 µM.
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produces a dorsalized phenotype (Müller et al., 1999; Dick 
et al., 2000), we injected RNA below the threshold of an 
observable phenotype and excluded any embryos exhibiting 
axis defects from analysis (Fig. 7, D and E). To improve 
survival of smad2ca and Atg MO coinjected embryos, we 
also reduced Atg MO concentration (150 µM), which in 
turn reduced the severe phenotype to 60%. Co-injecting 
smad2ca RNA with Atg MO nearly doubled the number of 
wild-type larvae (40%, n = 321 vs. Atg MO alone, 20%, 
n = 251; Fig. 7 D; P < 0.001). Therefore, the rbms3 mor-
phant cartilage defect is due, at least in part, to reduction in 
Tgf-r/Smad2 signaling.
Rbms3 regulates stability of smad2  
by binding to smad2 3 untranslated  
region (UTR)
In PCC, Rbms3 may regulate the stability of smad2 tran-
script and thus affect the pool of protein available for signal-
ing, as evidence suggests that Rbms3 can bind to the 3 UTRs 
observed (Fig. 5 B; P = 0.14), which suggests that in rbms3 
morphants, CNC-derived mesenchyme in the pharyngeal 
arches is specifically affected. Examination of runx2b (osteo-
genic lineage) also showed altered expression in rbms3 mor-
phants at 60 hpf (Fig. 5 A).
Rbms3 controls PCC cell proliferation
Nonspecific MO effects may indirectly cause craniofacial 
defects through the activation of the p53–apoptotic pathway 
(Robu et al., 2007). Tg(sox10(4.7):egfp) embryos coinjected 
with Atg MO and p53 MO failed to rescue the rbms3 mor-
phant cartilage phenotype, which suggests that the observed 
craniofacial defects were specifically caused by loss of rbms3 
(Fig. 6, A and B). Moreover, no significant difference in the 
numbers of Caspase-3+; EGFP+ cells were observed in the 
pharyngeal arches at 31 hpf between controls and rbms3 mor-
phants (Fig. 6 C).
In contrast, cell proliferation was markedly reduced in 
rbms3 morphants at 31 hpf (Co MO, n = 31; Atg MO, n = 27) 
and 48 hpf (Co MO, n = 33; Atg MO, n = 34), as assayed by 
PH3 expression in Tg(sox10(4.7):egfp) fish (Fig. 6 D; P < 
0.001). Comparison of sox10:egfp+ pharyngeal arch domains 
between controls and rbms3 morphants at 24 hpf showed no 
significant differences (Fig. 6 E), which suggests that the pro-
liferative differences observed between treatments at 31 hpf 
are not caused by significant loss of pharyngeal arch cells at 
early stages. Thus, Rbms3 functions in PCC by regulating 
cell proliferation.
Tgf-r signaling is reduced in  
rbms3 morphants
The CNC phenotype observed in rbms3 morphants is reminis-
cent of knockdown of mouse TGF-r2 in Wnt1-Cre mice (Ito 
et al., 2003; Wurdak et al., 2005). In both cases, the primary 
deficit is in the capacity of PCC to differentiate along the chon-
drogenic lineage because of an inability to maintain Sox9 expres-
sion. Furthermore, Smad2/3, effectors of the TGF-r2 pathway, 
promote Sox9-dependent transcriptional activity on the a1(II) 
collagen gene (Col2A1) enhancer and induce chondrogenesis 
in vitro (Furumatsu et al., 2005).
In zebrafish, smad2 is expressed by PCC at 26 hpf (Müller 
et al., 1999) and 31 hpf (Fig. 7 A). At 48 hpf, there was a re-
duction in transcription of both smad2 and tgf-r2a receptor 
in the pharyngeal arches of rbms3 morphants (Fig. 7 B; P < 
0.005). This also corresponded to reduced Smad2 protein lev-
els at 48 hpf in rbms3 morphant arches (Fig. 7 C); quantitation 
of band intensity revealed a ratio of 1:0.3 ± 0.05 (n = 3) in 
controls/morphants after normalization to -tubulin (Fig. 7 C). 
A reduction in phosphorylated Smad2 (pSmad2, reflecting ac-
tive Tgf- signaling) levels in rbms3 morphants at 31 hpf and 
48 hpf was also observed in the pharyngeal arches (Fig. 7 C). 
These results further support the hypothesis that the rbms3 mor-
phant cartilage phenotype may be caused by defects in Tgf-r 
signaling and that smad2 is a putative Rbms3 target.
We next tested whether constitutively activated smad2 
(smad2ca), which signals independently of TGF-r, was able 
to rescue the phenotype. Because injecting smad2ca alone 
Figure 5. PCC differentiation is affected in rbms3 morphants. (A) dlx2a 
PCC condensations are normal (1–4) yet PCC/chondrogenic (barx1, 
sox9a, and col2a1a) and osteogenic (runx2b) markers are severely af-
fected in morphants. Area highlighted by the broken lines and brackets: 
pharyngeal arch expression. Brackets: posterior arch expression. Bars, 
200 µM. (B) QPCR shows reduction in sox9a and barx1 in rbms3 mor-
phants. Error bars indicate SD. *, P < 0.005 (Student’s t test). n = indepen-
dent pools of RNA.
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Figure 6. Cell proliferation is defective in 
rbms3 morphants. (A and B) Co-injection of 
Atg MO with p53 MO does not rescue the 
cartilage phenotype. (A) Ventral views of MO-
injected fish. (B) Quantitation of the cartilage 
phenotype: Atg MO coinjected with p53 MO. 
P > 0.05 (2 test). n = number of larvae pooled 
from three experiments. Error bars indicate 
SD. (C) There is no difference in activated 
Caspase-3 (red) expression in the pharyngeal 
arches (green; 1–7) in rbms3 morphants. Lat-
eral view of MO-injected sox10:egfp fish at 31 
hpf and quantitation of bifluorescent activated 
Caspase-3+;sox10:egfp+ cells. Error bars indi-
cate SEM. P = 0.5 (Student’s t test). (D) Cell 
proliferation marker PH3 (red) is reduced in 
rbms3 morphant pharyngeal arches (green; 
1–7). Lateral view of MO-injected sox10:egfp 
fish at 31 hpf and quantitation of bifluorescent 
PH3+ and sox10:egfp+ cells in the pharyngeal 
arches at 31 and 48 hpf. Error bars indicate 
SEM. *, P < 0.0001 (Student’s t test). (E) Do-
main of pharyngeal arch (pa) sox10:egfp 
expression is comparable between MO treat-
ments at 24 hpf. Error bars indicate SD. n = 
number of fish (B–E). Bars: (A and C) 200 µM; 
(D) 100 µM.
Figure 7. Smad2 signaling is defective in rbms3 
morphants. (A) At 31 hpf, smad2 is expressed in 
the pharyngeal arches (numbered and highlighted). 
(B) QPCR shows that smad2 and tgf-r2a are reduced 
in rbms3 morphants at 48 hpf. Error bars indicate SD. 
*, P < 0.005 (two-tailed Student’s t test). n = indepen-
dent pools of RNA. (C) pSmad2 (top) and total Smad2 
(bottom) is reduced in rbms3 morphants. (D and E) 
Quantitation of phenotype (D) and cartilage staining 
(E) of fish coinjected with smad2ca and Atg MO. 
**, P < 0.001 (2 test). Bars, 200 µM.
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Rbms3 binds directly to multiple targets 
important for chondrogenesis
To test for direct binding, we performed RNA immunoprecipi-
tation (RIP). Either full-length Rbms3-Myc or truncated Rbms3 
lacking RNA binding domains (dRRM-Rbms3)-Myc was injected 
into zebrafish embryos, and c-Myc antibody was used to pull 
down associated mRNA transcripts (Fig. 8, E and F). Analysis of 
the Tgf-r pathway components in the Rbms3-Myc pull-downs 
revealed higher enrichment for smad2, smad3a, and smad3b com-
pared with tgf- receptors (compare purple with blue; Fig. 8 F). 
Other transcripts that were significantly enriched (more than 
fivefold; Fig. 8 F, broken red line) for full-length Rbms3 were 
cell cycle regulators (cyclin D1 and rac1) and smad1.
We tested specificity of binding for Rbms3 and found 
very little enrichment for the following transcripts. These tran-
scripts overlapped with observed domains of expression for en-
dogenous Rbms3 around 10–24 hpf: wnt3a, expressed in the 
isthmus and other neural tissues (Clements et al., 2009); the 
adhesion molecule cad2a (n-cad), ubiquitously expressed yet 
enriched in neural tissues (Harrington et al., 2007); and tran-
scription factors (myod and sox9a), both expressed in somites, 
with the latter also being expressed in the otic placodes (Fig. 8 F; 
Weinberg et al., 1996; Yan et al., 2005). These results suggest 
that posttranscriptional binding and stabilization of smad2 and 
other transcripts associated with the Tgf-r signaling pathway 
may be a direct mechanism by which Rbms3 regulates PCC 
differentiation into cartilage.
(Fritz and Stefanovic, 2007; Lu et al., 2012). To test if bind-
ing sites were harbored within the 3 UTR of zebrafish smad2, 
embryos were coinjected with full-length Rbms3 and de-
stabilized egfp (d1egfp) mRNA fused to smad2 3 UTR 
(d1egfp-smad2 3 UTR; Fig. 8, A–C). Comparing fish at 22–24 hpf 
injected with a truncated C-terminal version of rbms3 (dRRM-
rbms3; Fig. 8 A) versus full-length rbms3 showed higher d1EGFP 
protein and transcript levels (Fig. 8, B and C), which suggests that 
the d1egfp-smad2 3 UTR transcript half-life was extended with 
full-length Rbms3 (1.7 ± 0.3-fold increase, P = 0.05; Fig. 8 C, 
asterisk). In contrast, no difference in fluorescence was observed 
with smad2 3 UTR in the reverse orientation (smad2 3 UTR R), 
since it would not bind directly/indirectly to Rbms3 (P > 0.05) 
when coinjected with either rbms3 or dRRM-rbms3 (Fig. 8, 
B and C). The last 150 bp of smad2 3 UTR was found to harbor 
Rbms3-mediated stabilization sites (2.8 ± 0.2 fold, P < 0.05; 
Fig. 8 C, asterisk). However, the first 200 bp region of smad2  
3 UTR was found to destabilize the reporter transcript (Fig. 8 C; 
*, P < 0.05). Additionally, Rbms3 has no effect on sox9a 3 UTR 
(P = 0.7; Fig. 8 C). To further extend these findings, we tested 
d1egfp-smad2-150bp 3 UTR stability in the absence of endog-
enous Rbms3. Co- or Atg MO–treated embryos were coinjected 
with d1egfp-smad2-150bp 3 UTR, and Atg MO–treated em-
bryos had significantly less d1egfp transcript (*, P < 0.05) and 
protein levels compared with controls at 22–24 hpf (Fig. 8 D). 
Collectively, these results suggest that Rbms3 stabilizes smad2 
transcripts by acting on the last 150 bp of the smad2 3 UTR.
Figure 8. Smad2 transcripts are a target of Rbms3.  
(A) dRRM-Rbms3 lacks the putative RNA-binding domains 
(RRM; lower bracket, left). A schematic showing an in vivo 
stability assay is shown on the right. (B and C) Fluorescent 
images (B) and QPCR (C; d1egfp normalized to cherry) 
showing that full-length Rbms3 treatment stabilizes d1egfp-
smad2 3 utr and d1egfp-smad2 (150bp) 3 utr report-
ers. (D) Schematic shows the experiment (top left), QPCR 
(d1egfp normalized to cherry; bottom left), and fluorescent 
images (right) showing that Atg MO treatment destabilizes 
d1egfp-smad2 (150bp) 3 utr. (B and D) Images were taken 
under same brightness/contrast conditions. (E) Schematic 
of RIP experiment. (F) QPCR showing transcripts enriched 
(more than fivefold, red dotted line) for full-length Rbms3 
(n = 2–3 experiments). Error bars indicate SEM (C) and SD 
(D and F). n = RNA from individual embryos (C and D). 
*, P < 0.05 (Student’s t test). Bars, 500 µM.
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Craniofacial defects in rbms3 morphants 
resemble Tgf-r pathway defects in mice
We hypothesized that Rbms3 may modulate the TGF-r path-
way. Consistent with this possibility, rbms3 and smad2 (an ef-
fector of the TGF-r pathway) exhibit overlapping expression 
during CNC condensation in the pharyngeal arches (Figs. 1 
and 7). Mice conditionally deficient for the TGF-r2 pathway 
exhibit a similar cartilage phenotype to rbms3 morphants (Ito 
et al., 2003; Wurdak et al., 2005), although previous work in 
these mutant mice only concentrated on palatogenesis and no 
comment was made on the more posterior cartilage defects. 
As observed in Tgf-r2fl/fl; Wnt1-Cre mice, rbms3 morphants 
show a reduction in sox9a expression (Fig. 5) and cell pro-
liferation of PCC (Fig. 6), whereas pre-migratory and early 
migrating CNC appear (Fig. 4) normal, and cell death is unaf-
fected (Fig. 6).
The phenotypes observed in other TGF-r pathway 
mutants are not consistent with the overall rbms3 MO pheno-
type. In tgf-r3 morphants, survival of early neural crest is 
affected, resulting in a secondary cartilage phenotype (Cheah 
et al., 2010). The requirement for Tgf-r1 (Dudas et al., 2006) 
is significantly different from Tgf-r2 during chondrogenesis, 
suggesting that Tgf-r1 may participate in diverse signaling 
cascades during craniofacial development. Furthermore, sig-
naling via Tgf-r1 is not necessary for PCC proliferation but 
is required for survival (Dudas et al., 2006). Although it is true 
that Tgf-r1 can activate pSmad2, we suggest that reduction 
in observed Smad2 signaling is primarily caused by the Tgf-
r2–pSmad2 pathway deficiency.
Early PCC proliferation is likely to be regulated mainly 
through the TGF-r receptor pathway in a Smad-independent 
manner. Although Tgf-r2 null mice exhibit a cell proliferation 
defect (Ito et al., 2003), the mechanism by which this occurs 
has not been established during chondrocyte differentiation 
(Fig. 9 A, broken line). Previously, the small GTP-binding 
proteins Cdc42/Rac1 were shown to promote chondrocyte 
differentiation in mesenchyme condensations by promoting 
Sox9, Col2A, and N-cadherin expression (Woods et al., 2007). 
Additionally in a cell-dependent context, Cdc42 can activate 
cell proliferation in a Smad-independent manner after TGF-r 
activation in fibroblasts (Wilkes et al., 2003). Collectively, 
the decreased proliferation observed in rbms3 morphants is 
hypothesized to be a direct consequence of down-regulating 
components of the TGF-r pathway, likely in a Smad-indepen-
dent manner. In support of this, we find that the Tgf- receptor 
transcripts are enriched after immunoprecipitation for Rbms3 
(Fig. 8). The direct interactions between TGF-r signaling, 
Cdc42/Rac1, and cell cycle effectors remain unclear, but this 
study demonstrates that rac1 and cyclin D1 can be indepen-
dently regulated by Rbms3 (Fig. 8).
Although the cell proliferation defect is likely to be 
mainly Smad independent yet TGF-r signaling dependent, 
we suggest that an inability to generate cartilage and bone 
is caused by a Smad2 signaling deficiency in PCC progeni-
tors (Fig. 9). Atg MO treatment resulted in reduced levels 
of pSmad2 (indicative of active Tgf-r signaling), probably 
because of reduced Smad2 transcript and total protein levels 
Discussion
From a protein trap screen (Trinh et al., 2011), we isolated 
zebrafish rbms3, an RBP that belongs to the small family of 
MSSP (Penkov et al., 2000). For the first time, we have ana-
lyzed the in vivo developmental function for Rbms3. Here we 
report that Rbms3 is predominantly restricted to the cytoplasm 
and that rbms3 morphants exhibit severe craniofacial defects. 
Significantly, our results highlight a posttranscriptional role for 
Rbms3 in regulating one of the major pathways that promote 
chondrogenesis, the TGF-r pathway.
Rbms3 cells autonomously affect 
prechondrogenic transcription factors
Knockdown of rbms3 with two different MOs resulted in se-
vere craniofacial defects (Fig. 3). Early neural crest develop-
ment proceeded normally (Fig. 4). Although CNC migration 
to and condensation within the pharyngeal arches appeared 
unaffected in rbms3 morphants, pharyngeal arch expression 
domains of barx1, sox9a, col2a1a, and runx2b were severely 
reduced or affected (Fig. 5), which suggests a major role for 
Rbms3 during chondrogenesis.
CNC migration and condensation relies on interactions 
between CNC and their environment (Trainor and Tam, 1995; 
Trainor and Krumlauf, 2001; García-Castro et al., 2002; 
Trainor et al., 2002; Crump et al., 2004; Eberhart et al., 2006). 
Citrine tagged Rbms3 is expressed in the pharyngeal arches 
and the paraxial cranial mesoderm during CNC condensation 
in the arches (Figs. 1 and 2). High-resolution analysis in the 
Tg(sox10(7.2):mrfp) line revealed that Rbms3 is transiently 
expressed by PCC and excluded from differentiated cartilage 
while being maintained by surrounding tissues (Figs. 1 and 2). 
Collectively, the results suggest that Rbms3 promotes differ-
entiation of PCC to cartilage in a cell-autonomous manner.
Cell proliferation is reduced in  
rbms3 morphants
A fine balance between cell proliferation and apoptosis is es-
sential for proper cranial cartilage formation (Plaster et al., 
2006; Jones et al., 2008). Rbms3 morphants show a reduction 
in proliferating CNC (Fig. 6). This may be caused by (a) 
proliferative/apoptotic defects in the neuroepithelium, which 
influence the number of emigrating CNC; or (b) prolifera-
tive/apoptotic defects in the condensing ectomesenchyme. 
The former seems unlikely because Rbms3 is not expressed 
in the neuroepithelium during CNC induction. Additionally, 
condensation of CNC in the pharyngeal arches at 24 hpf is 
unaffected, and co-injecting rbms3 MO with p53 MO does 
not rescue the cartilage phenotype (Fig. 6). This differs from 
the flathead mutants, where decreased proliferation of CNC 
cells at 48 hpf and activation of the p53 pathway lead to a 
deficit in zygotic DNA polymerase 1, thus affecting carti-
lage morphogenesis. In contrast, in rbms3 morphants, lack of 
proliferation does not activate the p53 pathway or increase 
apoptosis (Fig. 6).
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Other pathways are regulated by Rbms3 
during chondrogenesis
While TGF-r signaling is a major pathway that promotes 
chondrogenesis, other signaling pathways also contribute to 
this process (Walshe and Mason, 2003a; Wada et al., 2005; 
Yoon et al., 2005; Eberhart et al., 2006; Sakai et al., 2006; 
de Frutos et al., 2007; Oka et al., 2008). In support of this, our 
data suggest that smad2ca alone is not sufficient to fully res-
cue the rbms3 morphant phenotype (Fig. 7). Mice deficient 
for Bmpr1a and Bmpr1b exhibit defects in PCC prolifera-
tion and differentiation (Yoon et al., 2005). Additionally, a 
zebrafish transgenic reporter for Smad1/5/8 and expression 
in morphants. Importantly, coinjection of capped smad2ca 
RNA with rbms3 MO significantly rescued the severe car-
tilage phenotype (Fig. 7), further supporting the notion that 
Rbms3 modulates the Tgf-r2 pathway during cartilage for-
mation (Fig. 9).
Rbms3 directly binds to smad2/3 
transcripts
The Tgf-r pathway is highly modulated during development 
to control the precise timing and duration of signaling (Liu, 
2003; Massagué et al., 2005). Steady-state levels of receptor 
Smads (such as Smad2) are regulated by the ubiquitin path-
way in a signal-dependent and -independent manner (Izzi and 
Attisano, 2004). Another possible mechanism for regulating 
protein levels is by altering the levels of transcript either by 
modulating the half-life of mRNA or altering accessibility 
of mRNA to translational machinery through compartmental-
ization of transcripts to different regions within the cell. This 
is facilitated by a multitude of RBPs and microRNAs (Lasko, 
2003; Keene, 2007). Evidence from the in vivo stability assay 
suggests that the smad2 3 UTR harbors Rbms3-binding 
sites (Fig. 8), thereby lending further support to the idea that 
smad2 levels and thus Smad2 steady-state protein levels are 
regulated by Rbms3. The region localized to the last 150 bp 
of smad2 3 UTR is sufficient to stabilize the reporter tran-
script. However, the first 200 bp of the smad2 3 UTR caused 
the reporter transcript to be destabilized, suggesting that there 
are “functional” domains within the smad2 3 UTR that both 
positively and negatively regulated by Rbms3. It may also 
reflect Rbms3 dependence for RNA secondary structure to 
facilitate binding of the Rbms3–RNP complex (Hiller et al., 
2006; Li et al., 2010). The requirement for endogenous Rbms3 
to stabilize smad2 150 bp 3 UTR and significant enrichment 
of smad2/3 transcripts after RIP for Rbms3 further provides 
evidence that Smad2 is a direct target (Fig. 8). Smad3 also 
participates during chondrocyte differentiation (Ferguson et al., 
2000; Yang et al., 2001) and is thus likely to be regulated 
directly by Rbms3.
The reduction observed in sox9a expression (Fig. 5) is 
also consistent with the hypothesis that Rbms3 is a modulator 
of the TGF-r pathway. Sustained Sox9 expression by condens-
ing prechondrogenic CNC requires active TGF-r2 signaling 
(Ito et al., 2003; Wurdak et al., 2005). Analysis of Sox9/ chi-
meric mice reveals that loss of Sox9 expression prevents PCC 
from differentiating into cartilage, which was formed entirely 
from wild-type cells, whereas Sox9/ cells, which also lacked 
Col2a1, were excluded (Bi et al., 1999). Conditional inactiva-
tion of Sox9 during CNC condensation maintains these cells in 
a mesenchymal state, as observed by a lack of Col2A1-positive 
cartilage extracellular matrix production (Akiyama et al., 2002). 
This is consistent with the finding that Smad2/3, effectors of the 
TGF-r2 pathway, promote Sox9-dependent transcription of 
Col2A1 in vitro (Furumatsu et al., 2005). Further support of the 
notion that loss of Smad2 is the primary defect and that sox9a 
loss in rbms3 morphants is a secondary outcome comes from 
the finding that the sox9a 3 UTR is unresponsive to Rbms3 and 
is not highly enriched during RIP (Fig. 8).
Figure 9. Rbms3 function during cartilage formation. (A) Schematic 
showing how the TGF-r signaling (Smad-dependent and -independent 
pathways) affects chondrocyte differentiation (top) and how chondrocytes 
differentiate from migrating CNC (bottom). Cells not responding to TGF-r 
signaling are in shaded gray boxes. Migrating CNC form PCC condensa-
tions in the pharyngeal arches. Here, Sox9+ (gray) CNC proliferate (black 
arrow) and receive TGF- signals (purple), which drives them down the 
chondrogenic lineage. During development, these cells gradually increase 
production of Col2a1 (graded red) and reach terminal differentiation. 
Rbms3 (graded green) is transiently expressed as CNC condense and is 
gradually excluded from committed chondrocytes. (B) Rbms3 functions to 
stabilize smad2 transcripts by binding to smad2 3 utr. This increases/
maintains the pool of Smad2 available to receive TGF-r signaling. Upon 
Tgf-r signaling, pSmad2–Smad4 complexes enter the nucleus (Liu, 2003) 
and bind to Sox9 to: (a) activate transcription of cartilage gene col2a1 
(Furumatsu et al., 2005), (b) maintain levels of sox9 (Ito et al., 2003; 
Wurdak et al., 2005), and (c) repress a battery of other transcription 
factors (Ito et al., 2003). This drives the PCC to proliferate and commit 
toward the chondrogenic lineage (Ito et al., 2003; Wurdak et al., 2005).
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MO injections
MOs were injected either into AB or AB/TL wild-type background. The 
translation start site MO (Atg MO) is as follows: 5-CGTTTGCCCATG-
TAGCTGGAATCCT-3. The splice MO (Sp MO) sequence is as follows: 
5-CATCTGGGAGAGACACTTACGGTTG-3. Atg MO stock injecting 
solution was at 160–120 µM and Sp MO was at 50 µM (unless other-
wise specified). 2.3 nl of the stock solution was injected per embryo at 
the 1–2-cell stage. For control injections, the standard MO, 5-CCTCT-
TACCTCAGTTACAATTTATA-3 (Co MO), was used. p53 MO injection 
stock solution was at 250 µM (Robu et al., 2007). All MOs were pur-
chased from Gene Tools, LLC. To detect splice variants generated by Sp 
MO, the following PCR primer pair was used: Exon2F, 5-AGAACCA-
CAAGCGGAGGCTTT-3; with Exon5/6R, 5-GTCCTGCTCTTGTTGCTTT-
GCCAT-3.
For rescue experiments with the Atg MO, a kozac sequence (5-GC-
CACC-3) was cloned immediately upstream of a mutagenized full-length 
rbms3 into pCS2+ at the Cla1–Xba1 sites. The endogenous first two co-
dons (indicated by underlines) following the start site (shown in bold letters; 
5-ATGGGCAAA-3) of rbms3 were changed to 5-ATG GGAAAG-3.
Imaging and image processing
For live confocal imaging, Gt(pwp2h-citrine)ct30a fish were soaked in 
BODIPY TR methyl ester vital dye (Invitrogen) for 30–60 min at 28°C to 
label all cells before mounting. Fish were anesthetized using 0.1% Tricaine, 
pH 7.2, in egg water and mounted laterally onto imaging molds (1% aga-
rose in egg water).
All confocal imaging was performed at room temperature. Confocal 
z-stack images ranging from 40 to 100 µM were acquired using a micro-
scope (LSM 510) and 25× LD LCI Plan-Apochromat NA 0.80 DIC 1 mm 
Korr or LD C-Apochromat 40×/1.1 W Korr UV-VIS-IR objective lenses (all 
from Carl Zeiss). LSM 510 version 4 software (Carl Zeiss) was used to 
acquire images.
Imaging of antibody-stained fish in whole-mount was performed 
as described for live confocal imaging earlier. Details of used fluoro-
chromes are described further on. Imaging for whole-mount in situ hy-
bridization and Alcian blue staining was performed using a microscope 
(Stemi SV 11; Carl Zeiss) with a Plan-Axiochromatic S 1.6× objective 
lens. Whole-mount images were acquired using AxioVision 4.6.3 soft-
ware (Carl Zeiss).
All confocal images were processed using ImageJ 1.38×. Brightness/
contrast processing of images was performed using Photoshop 7 (Adobe).
In situ hybridization and immunofluorescent staining
A combination of two probes for rbms3 were used: the first contained 
5 UTR and dRRM domains of rbms3 and was generated using 5-GTGT-
GGAGCAACCGGCAG-3 with 5-TAATACGACTCACTATAGGGTCT-
CAGTGGACTCCATTCTGGCAA-3 containing a T7 promoter (underlined) 
site. The second probe template spanned from the dRRM domains to the 
stop codon in pPCRII-TOPO (Invitrogen) and was generated using Not1 
and with SP6 RNA polymerase. In situ hybridization was performed as 
described previously (Jayasena et al., 2008). In brief, embryos or larvae 
were treated with phenylthiourea (PTU) to prevent pigmentation and fixed 
in 4% PFA. Fish older than 24 hpf were Proteinase K treated (20–100 
µg/ml depending on the stage) at room temperature. RNA probes were 
generated using SP6, T7, or T3 RNA polymerases, and hybridization was 
performed at 70°C. The citrine (Jayasena et al., 2011), dlx2a (Sperber 
et al., 2008), fgf3 (Walshe and Mason, 2003b), sox9a (Yan et al., 2005), 
sox10 (Dutton et al., 2001), foxd3 (Kelsh et al., 2000), pax2a (Pfeffer 
et al., 1998), barx1 (Sperber and Dawid, 2008), pax6 (Krauss et al., 
1991), hox2a (Prince et al., 1998), runx2b (Flores et al., 2004), col2a1a 
(Yan et al., 2002), and smad2 (Müller et al., 1999) probes have been 
described previously. Processed fish were imaged (as described earlier) in 
either PBS or 70% glycerol.
Immunofluorescent staining on deyolked fish was essentially 
performed as described previously (Ohyama et al., 2006). In brief, 
fish were fixed in 4% PFA made in 0.1 M phosphate buffer. Blocking, 
primary, and secondary antibody incubations were performed in 10% 
goat serum containing 0.5% Triton X-100 in PBS at either room temper-
ature (blocking step, 2–5 h) or 4°C (antibody incubations, 16–48 h). 
For confocal imaging, embryos were imaged in PBS. The following anti-
bodies were used: rabbit anti–phospho-histone H3 (PH3; EMD Millipore), 
rabbit anti-activated Caspase3 (R&D Systems), rabbit anti-GFP (Molecu-
lar Probes), goat anti–rabbit Alexa Fluor 488, and goat anti–rabbit 
Alexa Fluor 594 (Molecular Probes).
of smad1 also highlight a requirement for BMP signaling 
during chondrocyte development (Alexander et al., 2011; 
Laux et al., 2011). Collectively, we suggest that the cell pro-
liferation defect and the loss in sox9a expression could be 
partially caused by a loss of BMP–Smad1 signaling and rac1 
regulation by Rbms3 (Fig. 8).
A model for Rbms3 function during  
CNC development
Integrating these data, we propose a model for Rbms3 function 
during prechondrogenic CNC development in which Rbms3 
posttranscriptionally regulates components of the Tgf-r path-
way to influence the proliferative state and initial differentia-
tion of prechondrogenic CNC (Fig. 9). Previously, Prx1 and 
Ptf1a mRNA was demonstrated to be up-regulated by Rbms3 
through direct interaction with the Prx1/Ptf1a 3 UTR se-
quence (Fritz and Stefanovic, 2007; Lu et al., 2012). In a 
similar manner, we predict that Rbms3 influences transcript 
stability of Tgf-r pathway components (particularly smad2) 
and therefore transiently influences the timing and duration of 
Tgf-r signaling within CNC cells. Additionally, Rbms3 is likely 
to also regulate other components of the Smad2-independent 
pathway, such as cell cycle regulators and the BMP–Smad1 
pathway. Once these prechondrogenic cells become commit-
ted to form round chondrocytes, rbms3 expression is shut 
down in these cells. Under normal conditions, PCC are likely 
to be sensitive to levels of Tgf-r/BMP signaling and require 
a certain threshold of signaling to drive them down the chon-
drogenic lineage. In rbms3 morphants, a reduction in the pool 
of smad2 transcripts caused by reduced levels of Rbms3 is 
likely to directly influence the pool of Smad2 protein avail-
able in the cytoplasm that is able to respond to external Tgf- 
signals, thereby maintaining these cells in a mesenchymal 
state. Once prechondrogenic cells are driven into the carti-
lage lineage, we predict that the function of Rmbs3 in the 
CNC is complete. At this juncture, perhaps other RBPs or 
other mechanisms help maintain these cells in a committed 
chondrogenic state.
Materials and methods
Zebrafish husbandry and lines
Wild-type (AB or AB/TL background) and transgenic zebrafish lines (see 
below) were maintained according to institutional animal care and use 
protocols. Embryos were collected in egg water, maintained at 28°C, and 
staged according to Kimmel et al. (1995) based on somite number or 
landmark structural features.
Gt(rbms3-citrine)ct30a were maintained in a mixed AB/TL back-
ground. Previously published Tg(sox10(7.2):mrfp) (Kucenas et al., 2009) 
or Tg(sox10(4.7):egfp) (Dutton et al., 2008) were maintained in the 
AB background.
Cloning of rbms3
To retrieve the full-length rbms3, wild-type 42–48 hpf cDNA library 
was used to amplify full length and variants. 5 RACE was performed 
using the Generacer kit (Invitrogen) using 5-AGAGCGTTCCAGCCT-
CATCACAGGACGC-3 primer. 3 RACE was performed as described 
previously (Jayasena et al., 2011) using a 5-AGAGCGTTCCAGCCT-
CATCACAGGACGC-3 primer. For subcloning of full-length rbms3 con-
taining 5 UTR and open reading frame into pCS2+ at the Cla1–Xba1 
sites are: 5-GATCCCATCGATACAGCCAGAAGGATTCCAGCTAC-3 
and 5-TGAGGAGTAGAACCCGTTCTGCATTG-3.
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kit (Ambion) and treated with DNase1 (Invitrogen), then cDNA was gener-
ated using random hexamers with Superscript III (Invitrogen).
QPCR was performed using SYBR green reagent (Applied Bio-
systems) on 5–7 independent RNA pools (generated from 2–3 experi-
ments). For each QPCR primer set, amplification was performed in 
triplicate per pool of cDNA and validated for each MO treatment con-
dition at least three times. The housekeeping gene ef1 (Plaster et al., 
2006) was used as an internal control, and the results were analyzed 
using the comparative cycle threshold method for relative quantitation 
and normalized to ef1 levels.
For primer sequence details, see Table 1. All primer pairs showed 
100% efficiency. Because of high variation between experiments for 
controls, the fold change was set to 1 to facilitate direct comparison 
between experiments (different pools of RNA from different injection 
experiments). All samples were run in triplicate per primer pair. Error bars 
represent SD from biological replicates (independent pools of RNA) 
unless otherwise stated. Statistical tests were performed using the two-
tailed Student’s t test.
Generating capped mRNA and rescues
All DNA coding for desired mRNA were cloned into a pCS2+ vector and 
linearized with either Not1 or Kpn1 for generating capped mRNA using 
mMESSAGE mMACHINE SP6 kit (Ambion). For rescue of the MO phenotype, 
full-length mutagenized rbms3 (described earlier) was injected 20–30 pg/
embryo (as already described).
Smad2ca (Dick et al., 2000) was injected 15–30 pg/embryo, 
and Atg MO was coinjected at 150 µM. Trace amounts of egfp mRNA 
(5 pg/embryo) were also coinjected as a selection marker.
In vivo stabilization assay
Truncated rbms3 (dRRM-rbms3, lacking the putative RNA binding do-
mains [RRM], amino acids 210–415) was cloned into Cla1–Xba1 site 
in pCS2+. d1egfp from the O. Pourquie laboratory (Institute of Genetics 
and Molecular and Cellular Biology, Strasbourg, France) containing 
the PEST domain of mouse ornithine decarboxylase (d1egfp) was sub-
cloned into pCS2+ with EcoR1–Xba1 after the stop codon. The candidate 
3 UTR sequences were cloned into EcoR1–Xba1 site of pCS2+-d1egfp. 
pCS2+-cherryh2b was used as an injection control. Each embryo was 
injected with 70 pg of candidate 3 UTR, 60 pg rbms3/dRRM-rbms3, 
and 20 pg cherryh2b. Levels of d1egfp were normalized to levels of 
cherryh2b. For QPCR, RNA was extracted from 4–6 individual embryos 
collected from at least two independent experiments per condition. Nor-
malized fold change was graphed as mean ± SEM or SD, and a two-
tailed Student’s t test was performed. For 3 UTR and QPCR primer 
sequence details, see Tables 1 and 2.
Immunoblotting
To detect knockdown with Atg MO, Gt(rbms3-citrine)ct30a embryos treated 
with either Atg MO or Co MO at 48 hpf were deyolked in cold Ring-
er’s solution with 0.5 mM DTT and 0.2 mM phenylmethanesulfonylfluo-
ride (PMSF) supplemented with Complete protease inhibitors (EDTA free; 
Roche). For detecting Smad2 levels, 31-hpf head chunks (the region imme-
diately posterior of the eyes and anterior of the fin buds) were collected, 
and pharyngeal arches from the same region (without any neural tissue) at 
48 hpf were dissected in cold Ringer’s solution. Experiments were performed 
from at least three independent pools of protein extract. The following an-
tibodies were used: mouse anti–-tubulin (loading control; Sigma-Aldrich), 
rabbit anti-phosphorylated Smad2 (pSmad2; Cell Signaling Technology), 
rabbit anti-GFP (Invitrogen), rabbit anti-Smad2/3 (Cell Signaling Technol-
ogy), secondary anti-mouse HRP (Promega), and anti–rabbit HRP (Pro-
mega). Comparison of band intensity between loading control and Smad2 
was performed in ImageJ 1.38×. Loading control intensity was set to 1 and 
data were expressed as mean ± SD.
Alcian blue cartilage staining
Cartilage staining was performed essentially as described previously 
(Robu et al., 2007) in 0.1% Alcian blue, 70% ethanol, and 0.37% hydro-
chloric acid. Larvae were bleached with 3% H2O2 plus 1% KOH in PBS for 
20 min and treated with Trypsin (1 mg/ml; Sigma-Aldrich) for 30–60 min 
at 37°C. Experiments were performed at least three times to determine 
consistency. n values represent total number of larvae analyzed for the 
cartilage phenotype. Data were expressed as mean ± SD. To determine if 
there were statistical differences in phenotypes, between treatments, a 2 
test was performed.
Cell proliferation, cell death counts and area measurement
MO was injected into the Tg(sox10(4.7):egfp) background and im-
aged confocally. Cells positive for both EGFP and a marker of interest 
within the pharyngeal arches were counted. Data were expressed as 
bifluorescent cells/arch. The results were expressed as mean ± SEM, and 
statistical analysis was performed using a two-tailed Student’s t test. For 
pharyngeal arch area measurements, 0.1% Tricaine-, pH 7.2, treated 
embryos were imaged in whole-mount at 24 hpf in egg water at room 
temperature, as described for confocal imaging (Jayasena et al., 2011). 
Images were acquired using a microscope (MVX10; Olympus) attached 
to a 1× objective lens (MV PLAPO; Olympus) and AxioVision version 
4.6.3 software (Carl Zeiss). Images were processed using the ImageJ 
1.38× measure tool.
RNA extraction and QPCR
Pharyngeal arches removed of contaminating neural tissues/whole em-
bryos were collected. Total RNA was extracted using the RNAqueous-Micro 
Table 1. List of QPCR primers
Gene Forward primer Reverse primer
barx1 5-AAGTCCCACCGGAGACCTTCTAAA-3 5-ACAGAGGAGACACCGGAAACTTCA-3
cad2a 5-TGGTCCAGATACCCGTTGCTTTCA-3 5-AGCCTTGAACGTCAGTCAACCTCT-3
cherry 5-TCAAGACCACCTACAAGGCCAAGA-3 5-TGTGGGAGGTGATGTCCAACTTGA-3
cyclin D1 5-AGTATGCACGGATGCCCAAGTGTA-3 5-TCTTTGATGTCCAGCCATCACCCT-3
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smad5 5-TGTCTCGTAATGATGGGCTGACCT-3 5-TGGTGGCATTCTCCAGGTTGTGTA-3
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RIP
RIP with full-length Rbms3-Myc and dRRM-Rbms3-Myc was performed as 
described previously (Keene et al., 2006), at 4°C unless otherwise stated. 
Approximately 50 pg of rbms3-Myc or dRRM-rbms3-Myc capped mRNA 
was injected at the one-cell stage. Embryos (16–24 hpf) were deyolked 
manually with a pulled glass Pasteur pipette in cold zebrafish Ringer’s 
solution (116 mM NaCl, 2.9 mM KCl, 5 mM Hepes, pH 7, 20 mM vana-
dyl ribonucleoside complex [VRC; Sigma-Aldrich], and 1 mM DTT). Per 
10 ml of zebrafish Ringer’s solution, the following was added: 1 mini 
tablet EDTA-free protease inhibitors (Roche) and 10 µl of 0.2 M phenyl-
methanesulfonylfluoride (PMSF). To isolate total protein (0.5–1 mg), an 
Eppendorf pestle was used. About 100–150 µl of cold polysome lysis 
buffer (10 mM Hepes, pH 7.9, 100 mM KCl, 5 mM MgCl2, 1% IGEPAL 
CA-630, 1 mM DTT, 7× complete protease inhibitors [EDTA free; Roche], 
100 U/ml SuperaseIn (Ambion), and 250 U/ml RNaseOUT [Invitrogen]) 
was used, and lysate was stored at 80°C. Approximately 5 µg of mouse 
anti–c-Myc antibody (clone 9E10; Santa Cruz Biotechnology, Inc.) or 
mouse IgG (Santa Cruz Biotechnology, Inc.) were incubated with 50 µl of 
Dynabeads Protein G (Invitrogen) overnight in NT2 (50 mM Tris, pH 7.4, 
150 mM NaCl, and 1 mM MgCl2) containing 5% BSA and 0.05% IGE-
PAL CA-630. The beads were washed several times in NT2 plus 0.05% 
IGEPAL CA-630. Thawed lysate was centrifuged at 20,000 g for 10 min. 
The resulting supernatant (0.1× final total volume) was incubated with 
the beads in NT2 supplemented with 200 U/ml RNaseOut, 1 mM DTT, 
0.05% IGEPAL CA-630, and 20 mM EDTA for 2 h. All post-antibody in-
cubation washes were performed in NT2 plus 0.5% IGEPAL CA-630; the 
final three washes were also supplemented with 1 M urea. 2–3 indepen-
dent experiments were performed (mean ± SD). For calculations, QPCR 
results were initially normalized to input samples before calculating fold 
enrichment. Transcripts enriched greater than fivefold were considered to 
be significantly enriched. For primer sequence details, see Table 1.
Online supplemental material
Fig. S1 shows rbms3 expression at 16 and 18 hpf. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/ 
jcb.201204138/DC1.
We wish to thank the following people: Dr. Le. A. Trinh and Bronner labora-
tory members for helpful discussions and technical help, Ho-yin Leung for 
performing 3 RACE, and Leigh Ann Fletcher and David Mayorga from 
the Caltech Centers of Excellence in Genomic Science fish facility for 
fish maintenance.
This work was supported by the US Public Health Service Corps grants 
P50HG004071, DE017911, and HD037105 to M.E. Bronner.
Author contributions: C.S. Jayasena designed and performed the experiments, 
executed the data analysis, and wrote and edited the manuscript. M. Bronner 
performed data analysis and edited the manuscript.
Submitted: 26 April 2012
Accepted: 25 September 2012
References
Akiyama, H., M.-C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe. 
2002. The transcription factor Sox9 has essential roles in successive 
steps of the chondrocyte differentiation pathway and is required for 
expression of Sox5 and Sox6. Genes Dev. 16:2813–2828. http://dx.doi 
.org/10.1101/gad.1017802
Alexander, C., E. Zuniga, I.L. Blitz, N. Wada, P. Le Pabic, Y. Javidan, T. Zhang, 
K.W. Cho, J.G. Crump, and T.F. Schilling. 2011. Combinatorial roles 
for BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the 
Table 2. Primers used for subcloning candidate 3 UTRs into pCS2+-d1gefp
3 UTR Forward primer Reverse primer
smad2 3 utr 5-TGGACAAGGTTCTGACCCAGAT-3 5-CTACTACTAATACATTTAATATTGAGGGT-3
smad2 3 utr R (smad2 3 utr 
in the reverse orientation)
5-ACCCTCAATATTAAATGTATTAGTAGTAG-3 5-ATCTGGGTCAGAACCTTGTCCA-3
smad2 200bp 3 utr 5-TGGACAAGGTTCTGACCCAGAT-3 5-GGTCCGAACATCAGTATCGAGAGGA-3
smad2 150bp 3 utr 5-CTCGTGAGCCTTTCTTCTATCCTC-3 5-CTACTACTAATACATTTAATATTGAGGGTA-3
sox9a 3 utr 5-CCATCCCTCAATCCAACCACAGT-3 5-GTGTGTATACTATGGTTACCGATTTCAAAC-3
 o
n
 D
ecem
ber 6, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published October 22, 2012
465Rbms3 function during neural crest development • Jayasena and Bronner
McKeown, S.J., and M. Bronner-Fraser. 2008. Saving face: rescuing a cranio-
facial birth defect. Nat. Med. 14:115–116. http://dx.doi.org/10.1038/ 
nm0208-115
Müller, F., P. Blader, S. Rastegar, N. Fischer, W. Knöchel, and U. Strähle. 1999. 
Characterization of zebrafish smad1, smad2 and smad5: the amino-terminus 
of smad1 and smad5 is required for specific function in the embryo. Mech. 
Dev. 88:73–88. http://dx.doi.org/10.1016/S0925-4773(99)00173-2
Ohyama, T., O.A. Mohamed, M.M. Taketo, D. Dufort, and A.K. Groves. 2006. 
Wnt signals mediate a fate decision between otic placode and epidermis. 
Development. 133:865–875. http://dx.doi.org/10.1242/dev.02271
Oka, K., S. Oka, R. Hosokawa, P. Bringas Jr., H.C. Brockhoff II, K. Nonaka, 
and Y. Chai. 2008. TGF-beta mediated Dlx5 signaling plays a crucial 
role in osteo-chondroprogenitor cell lineage determination during man-
dible development. Dev. Biol. 321:303–309. http://dx.doi.org/10.1016/ 
j.ydbio.2008.03.046
Penkov, D., R. Ni, C. Else, S. Piñol-Roma, F. Ramirez, and S. Tanaka. 2000. 
Cloning of a human gene closely related to the genes coding for the 
c-myc single-strand binding proteins. Gene. 243:27–36. http://dx.doi.org/ 
10.1016/S0378-1119(99)00515-6
Pfeffer, P.L., T. Gerster, K. Lun, M. Brand, and M. Busslinger. 1998. 
Characterization of three novel members of the zebrafish Pax2/5/8 fam-
ily: dependency of Pax5 and Pax8 expression on the Pax2.1 (noi) func-
tion. Development. 125:3063–3074.
Plaster, N., C. Sonntag, C.E. Busse, and M. Hammerschmidt. 2006. p53 de-
ficiency rescues apoptosis and differentiation of multiple cell types 
in zebrafish flathead mutants deficient for zygotic DNA polymerase 
delta1. Cell Death Differ. 13:223–235. http://dx.doi.org/10.1038/sj.cdd 
.4401747
Prince, V.E., C.B. Moens, C.B. Kimmel, and R.K. Ho. 1998. Zebrafish hox 
genes: expression in the hindbrain region of wild-type and mutants of the 
segmentation gene, valentino. Development. 125:393–406.
Robu, M.E., J.D. Larson, A. Nasevicius, S. Beiraghi, C. Brenner, S.A. Farber, and 
S.C. Ekker. 2007. p53 activation by knockdown technologies. PLoS Genet. 
3:e78. http://dx.doi.org/10.1371/journal.pgen.0030078
Rogers, C.D., C.S. Jayasena, S. Nie, and M.E. Bronner. 2012. Neural crest speci-
fication: tissues, signals, and transcription factors. Wiley Interdisciplinary 
Reviews: Developmental Biology. 1:52–68. http://dx.doi.org/10.1002/ 
wdev.8
Sakai, D., T. Suzuki, N. Osumi, and Y. Wakamatsu. 2006. Cooperative action 
of Sox9, Snail2 and PKA signaling in early neural crest development. 
Development. 133:1323–1333. http://dx.doi.org/10.1242/dev.02297
Sauka-Spengler, T., and M. Bronner-Fraser. 2008. A gene regulatory network 
orchestrates neural crest formation. Nat. Rev. Mol. Cell Biol. 9:557–568. 
http://dx.doi.org/10.1038/nrm2428
Schilling, T.F., and C.B. Kimmel. 1994. Segment and cell type lineage restric-
tions during pharyngeal arch development in the zebrafish embryo. 
Development. 120:483–494.
Siomi, H., M.C. Siomi, R.L. Nussbaum, and G. Dreyfuss. 1993. The protein 
product of the fragile X gene, FMR1, has characteristics of an RNA-
binding protein. Cell. 74:291–298. http://dx.doi.org/10.1016/0092- 
8674(93)90420-U
Sperber, S.M., and I.B. Dawid. 2008. barx1 is necessary for ectomesenchyme 
proliferation and osteochondroprogenitor condensation in the zebraf-
ish pharyngeal arches. Dev. Biol. 321:101–110. http://dx.doi.org/ 
10.1016/j.ydbio.2008.06.004
Sperber, S.M., V. Saxena, G. Hatch, and M. Ekker. 2008. Zebrafish dlx2a 
contributes to hindbrain neural crest survival, is necessary for dif-
ferentiation of sensory ganglia and functions with dlx1a in matura-
tion of the arch cartilage elements. Dev. Biol. 314:59–70. http://dx.doi 
.org/10.1016/j.ydbio.2007.11.005
Takai, T., Y. Nishita, S.M.M. Iguchi-Ariga, and H. Ariga. 1994. Molecular clon-
ing of MSSP-2, a c-myc gene single-strand binding protein: characteriza-
tion of binding specificity and DNA replication activity. Nucleic Acids 
Res. 22:5576–5581. http://dx.doi.org/10.1093/nar/22.25.5576
Taylor, K.M., and C. LaBonne. 2005. SoxE factors function equivalently 
during neural crest and inner ear development and their activity is regu-
lated by SUMOylation. Dev. Cell. 9:593–603. http://dx.doi.org/10.1016/ 
j.devcel.2005.09.016
Trainor, P.A., and R. Krumlauf. 2001. Hox genes, neural crest cells and bran-
chial arch patterning. Curr. Opin. Cell Biol. 13:698–705. http://dx.doi 
.org/10.1016/S0955-0674(00)00273-8
Trainor, P.A., and P.P. Tam. 1995. Cranial paraxial mesoderm and neural crest 
cells of the mouse embryo: co-distribution in the craniofacial mesen-
chyme but distinct segregation in branchial arches. Development. 121: 
2569–2582.
Trainor, P.A., L. Ariza-McNaughton, and R. Krumlauf. 2002. Role of the 
isthmus and FGFs in resolving the paradox of neural crest plasticity 
Halbeisen, R.E., A. Galgano, T. Scherrer, and A.P. Gerber. 2008. Post- 
transcriptional gene regulation: from genome-wide studies to principles. 
Cell. Mol. Life Sci. 65:798–813. http://dx.doi.org/10.1007/s00018-007- 
7447-6
Harrington, M.J., E. Hong, O. Fasanmi, and R. Brewster. 2007. Cadherin-mediated 
adhesion regulates posterior body formation. BMC Dev. Biol. 7:130. 
http://dx.doi.org/10.1186/1471-213X-7-130
Hiller, M., R. Pudimat, A. Busch, and R. Backofen. 2006. Using RNA sec-
ondary structures to guide sequence motif finding towards single-
stranded regions. Nucleic Acids Res. 34:e117. http://dx.doi.org/10 
.1093/nar/gkl544
Hogan, D.J., D.P. Riordan, A.P. Gerber, D. Herschlag, and P.O. Brown. 2008. 
Diverse RNA-binding proteins interact with functionally related sets of 
RNAs, suggesting an extensive regulatory system. PLoS Biol. 6:e255. 
http://dx.doi.org/10.1371/journal.pbio.0060255
Ito, Y., J.Y. Yeo, A. Chytil, J. Han, P. Bringas Jr., A. Nakajima, C.F. Shuler, 
H.L. Moses, and Y. Chai. 2003. Conditional inactivation of Tgfbr2 in 
cranial neural crest causes cleft palate and calvaria defects. Development. 
130:5269–5280. http://dx.doi.org/10.1242/dev.00708
Izzi, L., and L. Attisano. 2004. Regulation of the TGFbeta signalling pathway 
by ubiquitin-mediated degradation. Oncogene. 23:2071–2078. http://dx 
.doi.org/10.1038/sj.onc.1207412
Jayasena, C.S., T. Ohyama, N. Segil, and A.K. Groves. 2008. Notch signal-
ing augments the canonical Wnt pathway to specify the size of the otic 
placode. Development. 135:2251–2261. http://dx.doi.org/10.1242/dev 
.017905
Jayasena, C.S., A. Trinh, and M. Bronner. 2011. Live imaging of endogenous 
Collapsin response mediator protein-1 expression at subcellular resolu-
tion during zebrafish nervous system development. Gene Expr. Patterns. 
11:395–400. http://dx.doi.org/10.1016/j.gep.2011.05.002
Jones, N.C., M.L. Lynn, K. Gaudenz, D. Sakai, K. Aoto, J.-P. Rey, E.F. Glynn, 
L. Ellington, C. Du, J. Dixon, et al. 2008. Prevention of the neurocristopa-
thy Treacher Collins syndrome through inhibition of p53 function. Nat. 
Med. 14:125–133. http://dx.doi.org/10.1038/nm1725
Keene, J.D. 2007. RNA regulons: coordination of post-transcriptional events. 
Nat. Rev. Genet. 8:533–543. http://dx.doi.org/10.1038/nrg2111
Keene, J.D., J.M. Komisarow, and M.B. Friedersdorf. 2006. RIP-Chip: the isola-
tion and identification of mRNAs, microRNAs and protein components 
of ribonucleoprotein complexes from cell extracts. Nat. Protoc. 1:302–
307. http://dx.doi.org/10.1038/nprot.2006.47
Kelsh, R.N., K. Dutton, J. Medlin, and J.S. Eisen. 2000. Expression of zebrafish 
fkd6 in neural crest-derived glia. Mech. Dev. 93:161–164. http://dx.doi 
.org/10.1016/S0925-4773(00)00250-1
Kimmel, C.B., W.W. Ballard, S.R. Kimmel, B. Ullmann, and T.F. Schilling. 
1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 
203:253–310. http://dx.doi.org/10.1002/aja.1002030302
Knecht, A.K., and M. Bronner-Fraser. 2002. Induction of the neural crest: a 
multigene process. Nat. Rev. Genet. 3:453–461. http://dx.doi.org/10 
.1038/nrg819
Krauss, S., T. Johansen, V. Korzh, and A. Fjose. 1991. Expression pattern of 
zebrafish pax genes suggests a role in early brain regionalization. Nature. 
353:267–270. http://dx.doi.org/10.1038/353267a0
Kucenas, S., W.-D. Wang, E.W. Knapik, and B. Appel. 2009. A selective 
glial barrier at motor axon exit points prevents oligodendrocyte migra-
tion from the spinal cord. J. Neurosci. 29:15187–15194. http://dx.doi 
.org/10.1523/JNEUROSCI.4193-09.2009
Lasko, P. 2003. Gene regulation at the RNA layer: RNA binding proteins in 
intercellular signaling networks. Sci. STKE. 2003:RE6. http://dx.doi.org/ 
10.1126/stke.2003.179.re6
Laux, D.W., J.A. Febbo, and B.L. Roman. 2011. Dynamic analysis of BMP-
responsive smad activity in live zebrafish embryos. Dev. Dyn. 240:682–
694. http://dx.doi.org/10.1002/dvdy.22558
Li, X., G. Quon, H.D. Lipshitz, and Q. Morris. 2010. Predicting in vivo binding 
sites of RNA-binding proteins using mRNA secondary structure. RNA. 
16:1096–1107. http://dx.doi.org/10.1261/rna.2017210
Li, Y., L. Chen, C.J. Nie, T.T. Zeng, H. Liu, X. Mao, Y. Qin, Y.H. Zhu, L. Fu, 
and X.Y. Guan. 2011. Downregulation of RBMS3 is associated with 
poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 
71:6106–6115. http://dx.doi.org/10.1158/0008-5472.CAN-10-4291
Liu, F. 2003. Receptor-regulated Smads in TGF-beta signaling. Front. Biosci. 
8:s1280–s1303. http://dx.doi.org/10.2741/1149
Lu, C.K., Y.C. Lai, H.R. Chen, and M.K. Chiang. 2012. Rbms3, an RNA-bind-
ing protein, mediates the expression of Ptf1a by binding to its 3’UTR 
during mouse pancreas development. DNA Cell Biol. 31:1245–1251. 
http://dx.doi.org/10.1089/dna.2012.1619
Massagué, J., J. Seoane, and D. Wotton. 2005. Smad transcription factors. Genes 
Dev. 19:2783–2810. http://dx.doi.org/10.1101/gad.1350705
 o
n
 D
ecem
ber 6, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published October 22, 2012
JCB • VOLUME 199 • NUMBER 3 • 2012 466
and prepatterning. Science. 295:1288–1291. http://dx.doi.org/10.1126/ 
science.1064540
Trinh, A., T. Hochgreb, M. Graham, D. Wu, F. Ruf-Zamojski, C.S. Jayasena, 
A. Saxena, R. Hawk, A. Gonzalez-Serricchio, A. Dixson, et al. 2011. A 
versatile gene trap to visualize and interrogate the function of the ver-
tebrate proteome. Genes Dev. 25:2306–2320. http://dx.doi.org/10.1101/ 
gad.174037.111
Wada, N., Y. Javidan, S. Nelson, T.J. Carney, R.N. Kelsh, and T.F. Schilling. 
2005. Hedgehog signaling is required for cranial neural crest morphogen-
esis and chondrogenesis at the midline in the zebrafish skull. Development. 
132:3977–3988. http://dx.doi.org/10.1242/dev.01943
Walshe, J., and I. Mason. 2003a. Fgf signalling is required for formation of car-
tilage in the head. Dev. Biol. 264:522–536. http://dx.doi.org/10.1016/ 
j.ydbio.2003.08.010
Walshe, J., and I. Mason. 2003b. Unique and combinatorial functions of 
Fgf3 and Fgf8 during zebrafish forebrain development. Development. 
130:4337–4349. http://dx.doi.org/10.1242/dev.00660
Weinberg, E.S., M.L. Allende, C.S. Kelly, A. Abdelhamid, T. Murakami, P. 
Andermann, O.G. Doerre, D.J. Grunwald, and B. Riggleman. 1996. 
Developmental regulation of zebrafish MyoD in wild-type, no tail and 
spadetail embryos. Development. 122:271–280.
Wilkes, M.C., S.J. Murphy, N. Garamszegi, and E.B. Leof. 2003. Cell-type-
specific activation of PAK2 by transforming growth factor beta indepen-
dent of Smad2 and Smad3. Mol. Cell. Biol. 23:8878–8889. http://dx.doi 
.org/10.1128/MCB.23.23.8878-8889.2003
Woods, A., G. Wang, H. Dupuis, Z. Shao, and F. Beier. 2007. Rac1 signaling 
stimulates N-cadherin expression, mesenchymal condensation, and chon-
drogenesis. J. Biol. Chem. 282:23500–23508. http://dx.doi.org/10.1074/
jbc.M700680200
Wurdak, H., L.M. Ittner, K.S. Lang, P. Leveen, U. Suter, J.A. Fischer, S. 
Karlsson, W. Born, and L. Sommer. 2005. Inactivation of TGFbeta 
signaling in neural crest stem cells leads to multiple defects remi-
niscent of DiGeorge syndrome. Genes Dev. 19:530–535. http://dx.doi 
.org/10.1101/gad.317405
Yan, Y.-L., C.T. Miller, R.M. Nissen, A. Singer, D. Liu, A. Kirn, B. Draper, J. 
Willoughby, P.A. Morcos, A. Amsterdam, et al. 2002. A zebrafish sox9 
gene required for cartilage morphogenesis. Development. 129:5065–
5079. (published erratum appears in Development. 2002. 129:5551)
Yan, Y.-L., J. Willoughby, D. Liu, J.G. Crump, C. Wilson, C.T. Miller, A. 
Singer, C. Kimmel, M. Westerfield, and J.H. Postlethwait. 2005. A pair of 
Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs 
in craniofacial and pectoral fin development. Development. 132:1069–1083. 
http://dx.doi.org/10.1242/dev.01674
Yang, X., L. Chen, X. Xu, C. Li, C. Huang, and C.X. Deng. 2001. TGF-/Smad3 
signals repress chondrocyte hypertrophic differentiation and are required 
for maintaining articular cartilage. J. Cell Biol. 153:35–46. http://dx.doi 
.org/10.1083/jcb.153.1.35
Yoon, B.S., D.A. Ovchinnikov, I. Yoshii, Y. Mishina, R.R. Behringer, and 
K.M. Lyons. 2005. Bmpr1a and Bmpr1b have overlapping functions 
and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA. 
102:5062–5067. http://dx.doi.org/10.1073/pnas.0500031102
 o
n
 D
ecem
ber 6, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published October 22, 2012
